Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
53.4M
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
7.67M
-
Shares change
-
+5.35M
-
Total reported value, excl. options
-
$98.3M
-
Value change
-
+$70.5M
-
Put/Call ratio
-
0.39
-
Number of buys
-
47
-
Number of sells
-
-21
-
Price
-
$12.82
Significant Holders of ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (ZVRA) as of Q2 2021
95 filings reported holding ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share as of Q2 2021.
ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (ZVRA) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.67M shares
of 53.4M outstanding shares and own 14.35% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.97M shares), VANGUARD GROUP INC (1.21M shares), Hudson Bay Capital Management LP (723K shares), STATE STREET CORP (494K shares), GEODE CAPITAL MANAGEMENT, LLC (473K shares), BOOTHBAY FUND MANAGEMENT, LLC (441K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (359K shares), NORTHERN TRUST CORP (278K shares), Janney Montgomery Scott LLC (259K shares), and CVI Holdings, LLC (244K shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.